Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piracetam SCHEMBL6140872 | 1.00 | TSHR (1.00) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 | |
| Piracetam SCHEMBL28423013 | 0.98 | TSHR (0.96) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL24263535 | 0.94 | TSHR (0.89) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL1532937 | 0.92 | TSHR (0.85) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL8552055 | 0.87 | — | — | |
| Piracetam SCHEMBL1756178 | 0.83 | TSHR (0.69) | TSHRHTTKMT2ASMN1; SMN2ALDH1A1 | |
| 4,4'-Methylenedianiline SCHEMBL20770172 | 0.83 | TSHR (0.69) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL22446137 | 0.82 | TSHR (0.69) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL948990 | 0.81 | TSHR (0.68) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL9628927 | 0.81 | TSHR (0.67) | TSHRPIK3CDHTTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9843 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746864-A1 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | Keto Innovations, LLC (US) | 2026-05-27 | — | — | EP | claimed |
| CN-116850183-B | Methods and pharmaceutical compositions for treating myopia | GRAND PHARMA (CHINA) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260137654-A1 | COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER | THE REGENTS OF THE UNIV OF CALIFORNIA (US) | 2026-05-21 | — | — | US | claimed |
| EP-4744670-A1 | POLYLACTIC ACID AND USE OF COPOLYMER THEREOF IN PREPARATION OF DRUG FOR PROMOTING NERVE GROWTH AND REPAIR | Changchun Sinobiomaterials Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| WO-2026090582-A1 | COMPOSITIONS CONTAINING A NON-XANTHINE CNS STIMULANT OR NOOTROPIC AND BETA-HYDROXYBUTYRATE OR PRECURSOR FOR INCREASING NEUROLOGICAL AND PHYSIOLOGICAL PERFORMANCE | AXCESS GLOBAL SCIENCES, LLC (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260097008-A1 | ACETYL LEUCINE FOR USE IN TREATING NIEMANN-PICK DISEASE TYPE C | INTRABIO INC. | 2026-04-09 | — | — | US | claimed |
| US-20260083706-A1 | 5HT AGONISTS FOR TREATING DISORDERS | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | claimed |
| EP-4712954-A1 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION | Keto Innovations, LLC (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4696377-A2 | 5HT AGONISTS FOR TREATING DISORDERS | The Regents of the University of California (US) | 2026-02-18 | — | — | EP | claimed |
| US-12498384-B2 | Biomarkers and methods for evaluation and treatment of epileptic vs non-epileptic seizures / no seizures / psychogenic non-epileptic seizures | COGNIZANCE BIOMARKERS, INC. (US) | 2025-12-16 | — | — | US | claimed |
| EP-0213326-A1 | 2,5-Dimethyl pyrrole derivatives, their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1987-03-11 | — | — | EP | claimed |
| EP-0205247-A2 | Derivatives of quinuclidine | STATE OF ISRAEL, REPRESENTED BY PRIME MINISTER'S OFFICE, ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) | 1986-12-17 | — | — | EP | claimed |
| US-4620973-A | PREVENTION OF SIDE EFFECTS OF ANTITUMOR AGENTS | CIBA GEIGY CORPORATION (US) | 1986-11-04 | — | — | US | claimed |
| EP-0050589-B1 | PHARMACEUTICAL COMPOSITIONS WITH AN ANTI-EPILEPTIC AND ANTI-NEURALGIC EFFECT, AND PROCESS FOR THEIR MANUFACTURE | CIBA-GEIGY AG (CH) | 1984-09-12 | — | — | EP | claimed |
| EP-0116238-A1 | Therapeutic compositions and their use in enhancing brain function | BIOMEASURE, INC. (US) | 1984-08-22 | — | — | EP | claimed |
| US-4431641-A | AN ANTICONVULSANT DIBENZ/B,F/AZEPINE POTENTIATED BY A VINCAMINE OR PIRACETAM DERIVATIVE | CIBA-GEIGY CORPORATION (US) | 1984-02-14 | — | — | US | claimed |
| US-4385053-A | ADMINISTERING LECITHIN AND PIRACETAM | NEW YORK UNIVERSITY, A CORP. | 1983-05-24 | — | — | US | claimed |
| US-4355027-A | Process and composition for treating disorders by administering piracetam and choline | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1982-10-19 | — | — | US | claimed |
| EP-0050589-A1 | Pharmaceutical compositions with an anti-epileptic and anti-neuralgic effect, and process for their manufacture | CIBA-GEIGY AG (CH) | 1982-04-28 | — | — | EP | claimed |
| US-4115579-A | 2-OXO-1-PYRROLIDINEACETAMIDE, 2-(2-OXOPYRROLIDINO)PROPIONAMIDE OR 2-(2-OXOPYRROLIDINO)BUTYRAMIDE | U C B, SOCIETE ANONYME (BE) | 1978-09-19 | — | — | US | claimed |